Drug Shortage Report for SCOPOLAMINE HYDROBROMIDE INJECTION USP

Last updated on 2017-08-09 History
Report ID 1099
Drug Identification Number 00541869
Brand name SCOPOLAMINE HYDROBROMIDE INJECTION 0.4MG/ML
Common or Proper name SCOPOLAMINE
Company Name PFIZER CANADA ULC
Market Status CANCELLED POST MARKET
Active Ingredient(s) SCOPOLAMINE HYDROBROMIDE
Strength(s) 0.4mg
Dosage form(s) Solution
Route of administration INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS
Packaging size 0.4mg/mL x 10
ATC code A04AD
ATC description ANTIEMETICS AND ANTINAUSEANTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2015-07-28
Estimated end date 2017-08-11
Actual end date 2017-08-08
Shortage status Resolved
Updated date 2017-08-09
Company comments Resolved August 8, 2017 Product Distribution on Hold
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2017-03-13 English Compare
v2 2017-03-13 French Compare
v3 2017-03-13 English Compare
v4 2017-03-13 French Compare
v5 2017-03-14 English Compare
v6 2017-03-14 French Compare
v7 2017-06-29 English Compare
v8 2017-06-29 English Compare
v9 2017-06-29 French Compare
v10 2017-07-19 English Compare
v11 2017-07-19 French Compare
v12 2017-07-31 English Compare
v13 2017-07-31 French Compare
v14 2017-08-08 English Compare
v15 2017-08-08 English Compare
v16 2017-08-08 French Compare
v17 2017-08-09 English Compare

Showing 1 to 17 of 17